Steven W. Lefkowitz
CIK: 0001313149
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CorMedix Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 26, 2026CRMD
CorMedix Inc.
Award(A)Direct30.5K shares- - Jan 12, 2026CRMD
CorMedix Inc.
Exercise(M)Direct15K shares at avg. $5.63$84K - Dec 9, 2025CRMD
CorMedix Inc.
Sale(S)Direct40K shares at avg. $11.88$475K - Apr 2, 2025CRMD
CorMedix Inc.
Exercise(M)Direct20K shares at avg. $4.03$81K - Jan 17, 2025CRMD
CorMedix Inc.
Award(A)Direct25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 26, 2026 | CRMD CorMedix Inc. | Award(A) | 30,453 | - | $0 | Direct |
| Jan 12, 2026 | CRMD CorMedix Inc. | Exercise(M) | 15,000 | $5.63 | $84,450 | Direct |
| Dec 9, 2025 | CRMD CorMedix Inc. | Sale(S) | 40,000 | $11.88 | $475,200 | Direct |
| Apr 2, 2025 | CRMD CorMedix Inc. | Exercise(M) | 20,000 | $4.03 | $80,600 | Direct |
| Jan 17, 2025 | CRMD CorMedix Inc. | Award(A) | 25,000 | - | $0 | Direct |
1-5 of 5 transactions
About Lefkowitz Steven W
Lefkowitz Steven W (SEC CIK 0001313149) files insider reports with the SEC as Director of CorMedix Inc. (CRMD).
Signal8 holds 5 ownership filings by Lefkowitz Steven W, all Form 4s, filed between Jan 22, 2025 and Jan 27, 2026. Those filings report 5 transactions, from Jan 17, 2025 to Jan 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lefkowitz Steven W's filings is in BERKELEY HEIGHTS, NJ.
Recent filings by Lefkowitz Steven W
- Jan 26, 2026: Grant or award of CRMD shares (Form 4, code A).
- Jan 12, 2026: Option exercise of CRMD shares (Form 4, code M).
- Dec 9, 2025: Open-market sale of CRMD shares (Form 4, code S).
- Apr 2, 2025: Option exercise of CRMD shares (Form 4, code M).
- Jan 17, 2025: Grant or award of CRMD shares (Form 4, code A).
Other insiders filing for CorMedix Inc. (CRMD)
- Dillione Janet, Director
- Blum Susan, Chief Financial Officer
- Hurlburt Elizabeth, Chief Operating Officer
- Zelnick Kaufman Beth, Chief Legal Officer
- Todisco Joseph, Chief Executive Officer
- Kaplan Myron, Director